Cochrane, a global independent network of researchers, professionals, patients, carers, and health enthusiasts is celebrating our 30th anniversary in 2023.

Cochrane workshop «Evidence-based clinical guidelines for the safety of pharmacotherapy», organized by Cochrane Russia together with Cochrane China, was held as a part of the Russian congress «Safety of pharmacotherapy 360°: Noli nocere!» at RMANPO on May 18, 2023. Rector of RMANPO, Academician of the Russian Academy of Sciences Dmitry Alekseevich Sychev and Senior Officer of US Network & Geographic Groups and Cochrane Central Executive Team Tiffany Duque addressed the participants of the workshop with a welcoming speech.

Russian congress «SAFETY OF PHARMACOTHERAPY 360°: NOLI NOCERE! » Cochrane Russia Workshop: Evidence-Based Clinical Guidelines for the Safety of Pharmacotherapy «SAFETY OF PHARMACOTHERAPY 360°: NOLI NOCERE!» congress registration here Moderators:

Registration is now open for the 2023 Cochrane Colloquium. Register before the 01 June 2023 to get the reduced early bird rate

Cochrane London 2023: Forward together for trusted evidence4-6 September 2023Central London, UK

A comprehensive review of all the evidence available from randomised controlled trials of COVID 19 vaccines up to November 2021 has concluded that most protect against infection and severe or critical illness caused by the virus.

On International Volunteer Day, 5 December, we would like to take the opportunity to say thank you to our incredible global community. Thank you to thousands of Cochrane Supporters and Members who volunteer in so many ways to help bring trusted health evidence to the people who need it, all over the world.

Cochrane London 2023: Forward together for trusted evidence4-6 September 2023Central London, UK

Dear Colleagues,

The 2021 Journal Citation Report has been released by Clarivate Analytics, and we are delighted to announce that the Journal Impact Factor for the Cochrane Database of Systematic Reviews (CDSR) is now 12.008.